Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma".
David A Sandham,Lucy Barker,Lyndon Brown,Zarin Brown,David Budd,Steven J Charlton,Devnandan Chatterjee,Brian Cox,Gerald Dubois,Nicholas Duggan,Edward Hall,Julia Hatto,Catherine Leblanc,Janet Maas,Jodie Manini,Rachael Profit,Darren Riddy, Catherine Ritchie,Bindi Sohal,Duncan Shaw,Rowan Stringer,David A Sykes,Matthew Thomas,Katharine L Turner,Simon J Watson,Ryan West, Elisabeth Willard,Gareth Williams,Jennifer Willis ACS medicinal chemistry letters(2017)
摘要
[This corrects the article DOI: 10.1021/acsmedchemlett.7b00157.].
更多查看译文
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)